Publication | Closed Access

Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting α-synuclein abnormalities in the substantia nigra

Motor ImpairmentSynaptic TransmissionGinsenoside Rg1Synaptic SignalingSocial SciencesNeuroinflammationNeurobiology Of DiseaseDegenerative PathologyNeurologyNeuroimmunologyNeuropharmacologyNeuroprotectionNeurodegenerationPharmacologySynaptic PlasticityNeurodegenerative DiseasesSubstantia NigraCellular NeuroscienceNeuroscienceMedicine